Severe CMV complication following maintenance therapy with rituximab
- PMID: 23307449
- PMCID: PMC3603828
- DOI: 10.1136/bcr-2012-006672
Severe CMV complication following maintenance therapy with rituximab
Abstract
Cytomegalovirus (CMV) encephalitis is a rare infection that immunodeficient patients, mainly where HIV-positive, may suffer from. Several cases were described when complications with the treatment with monoclonal antibodies, like rituximab, for malignant lymphomas. We will describe here the case of a patient, who has developed CMV gastritis, then CMV encephalitis after the treatment of a CLL with a chemotherapy and maintenance therapy with rituximab.
Figures
References
-
- Keating MJ, O'Brien S, Albitar M, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol 2005;23:4079–88 - PubMed
-
- Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol 2010;47:187–98 - PubMed
-
- Aksoy S, Harputluoglu H, Kilickap S, et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 2007;48:1307–12 - PubMed
-
- Berthelot J-M, Jamin C, Amrouche K, et al. Regulatory B cells play a key role in immune system balance. Joint Bone Spine (Internet) 2012. juill 31 (cité 2012 sept 3); http://www.ncbi.nlm.nih.gov/pubmed/22858147 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical